Primary Mediastinal Yolk Sac Tumors: An Immunohistochemical Analysis of 14 Cases.


Journal

Applied immunohistochemistry & molecular morphology : AIMM
ISSN: 1533-4058
Titre abrégé: Appl Immunohistochem Mol Morphol
Pays: United States
ID NLM: 100888796

Informations de publication

Date de publication:
02 2019
Historique:
pubmed: 20 9 2016
medline: 6 5 2020
entrez: 20 9 2016
Statut: ppublish

Résumé

Primary mediastinal germ cell tumors are uncommon tumors that can pose diagnostic difficulties due to their morphologic spectrum and unusual site. Immunohistochemistry plays an increasing role in the diagnosis of these tumors. Whereas the immunophenotype of testicular yolk sac tumors (YST) is rather well known, the opposite is true for primary mediastinal YST leading us to investigate the immunohistochemical features of 14 such neoplasms. Fourteen cases of primary mediastinal YST were reviewed and representative whole tissue sections were selected for immunohistochemical analysis using antibodies directed against CAM5.2, SALL4, OCT3/4, glypican-3, CD30, α-fetoprotein (AFP), CD117, placental alkaline phosphatase (PLAP), GATA-3, and CDX2. The percentage of positive tumor cells and the intensity of staining were evaluated and scored. All cases (100%) showed strong and diffuse expression of CAM5.2 and SALL4, 10 cases (71%) reacted with glypican-3 and AFP in a patchy manner, 5 cases (36%) showed focal positivity with PLAP and GATA-3, 4 cases (29%) showed staining for CDX2, 3 (21%) showed expression of CD117, and a single case was positive for CD30 (7%). None of the cases showed any staining for OCT3/4. Primary mediastinal YST appear to have a similar immunohistochemical phenotype as their testicular counterparts. Coexpression of CAM5.2, SALL4, glypican-3, and AFP provides the best support for YST differentiation; however, it has to be noted that none of these markers is specific for these tumors and immunohistochemical results will always have to be interpreted in the context of morphologic, clinical, and radiologic information.

Identifiants

pubmed: 27643524
doi: 10.1097/PAI.0000000000000442
doi:

Substances chimiques

Biomarkers 0
CAM 5.2 antigen 0
Octamer Transcription Factor-3 0
POU5F1 protein, human 0
SALL4 protein, human 0
Transcription Factors 0
Keratins 68238-35-7

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

125-133

Auteurs

Annikka Weissferdt (A)

Departments of Pathology.

Neda Kalhor (N)

Departments of Pathology.

Jaime Rodriguez Canales (J)

Translational Molecular Pathology, MD Anderson Cancer Center, Houston, TX.

Junya Fujimoto (J)

Translational Molecular Pathology, MD Anderson Cancer Center, Houston, TX.

Ignacio I Wistuba (II)

Translational Molecular Pathology, MD Anderson Cancer Center, Houston, TX.

Cesar A Moran (CA)

Departments of Pathology.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH